What Fueled The Previous Growth In The Ovulation Testing Kits Market?
The ovulation testing kits market has seen considerable growth due to a variety of factors.
• The ovulation testing kits market has grown rapidly in recent years. It will rise from $3.02 billion in 2024 to $3.34 billion in 2025, at a compound annual growth rate (CAGR) of 10.7%.
This growth is attributed to increased awareness of fertility, a growing trend of family planning, heightened focus on women’s health, more availability of over-the-counter options, and a rising demand for accurate ovulation testing kits.
How Does the Forecast Look for the Ovulation Testing Kits Market?
The ovulation testing kits market is expected to maintain its strong growth trajectory in upcoming years.
• The ovulation testing kits market is expected to reach $4.95 billion by 2029, growing at a CAGR of 10.3%.
The growth is driven by the expanding global population, rising birth rates, increased fertility issues, delayed childbearing, greater adoption of digital health solutions, and wider access to healthcare in emerging markets. Trends include personalized fertility tracking, AI integration for ovulation prediction, wearable fertility trackers, eco-friendly testing options, and the rise of telemedicine and remote monitoring for fertility management.
What Are The Leading Drivers Of Growth In The Ovulation Testing Kits Market?
The ovulation testing kits market is predicted to be boosted by the falling fertility rates. The term "fertility rates" refers to the count of live births in a population during a certain time period, usually measured as births per 1,000 women within the reproductive age group (usually 15-49 years old) per annum. A decrease in fertility rates can be attributed to greater educational and career opportunities for women, better access to and usage of contraceptives, postponement of marriage and childbearing, and a high cost of living. Ovulation testing kits provide an easy-to-use, non-invasive solution for individuals or couples dealing with low fertility rates, as they help in determining the best time for sexual intercourse to increase the likelihood of conception. For instance, the Office for National Statistics, a British government agency, reported in October 2024 that the total fertility rate (TFR) in England and Wales had dropped from an average of 1.49 children per woman during her reproductive life to 1.44 - the lowest figure ever recorded between 2022 and 2023. Hence, the diminishing fertility rates are contributing to the expansion of the ovulation testing kits market.
How Are The Segments Defined Within The Global Ovulation Testing Kits Market?
The ovulation testing kits market covered in this report is segmented –
1) By Product Type: Urine-Based, Saliva-Based, Salivary Ferning
2) By Distribution Channel: Pharmacies And Drugstores, Hypermarkets And Supermarkets, E-Commerce, Other Distribution Channels
3) By End User: Hospitals, Clinics, Diagnostic Centers, Fertility Centers, Home Care Settings, Other End Uses
Subsegments:
1) By Urine-Based: Dipstick Tests, Midstream Tests, Digital Urine Tests
2) By Saliva-Based: Saliva Ovulation Test Strips, Saliva Test Kits with Magnification
3) By Salivary Ferning: Ferning Microscopes, Ferning Test Kits
Pre-Book The Ovulation Testing Kits Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Market Trends Are Altering The Ovulation Testing Kits Industry?
Leading firms in the ovulation testing kits industry are concentrating on establishing strategic partnerships to obtain a market advantage. This implies joint efforts by significant industry players to bolster their market dominance, broaden their product range, and leverage burgeoning opportunities. These associations comprise alliances, partnerships, cooperative initiatives, and contracts among manufacturers, distributors, health care providers, and other relevant stakeholders aimed at achieving shared goals and promoting market growth. For instance, Innova Medical Group, a U.S-based health care firm that produces antigen tests for COVID-19, formed a partnership with iXensor, a Taiwan-based company that provides a tech platform for mobile health diagnosis. In November 2022, they launched 'PHRONESIA Smart Ovulation Test, a smart ovulation test. It utilizes PixoTech technology and is powered by iXensor Technology. The PixoTech technology could fulfill the increasing need for convenient at-home testing by working cooperatively with lateral flow assay producers, pharmaceutical firms, and MedTech innovators.
Who Are the Key Players In The Ovulation Testing Kits Market?
Major companies operating in the ovulation testing kits market are:
• Church & Dwight Co Inc.
• Piramal Enterprises Inc.
• Meril Diagnostics Pvt Ltd.
• Roman Health Ventures Inc.
• BIOSYNEX SA
• Boditech Med Inc.
• Mankind Pharma Ltd.
• Innovita Biological Technology Co.Ltd.
• Hangzhou Clongene Biotech Co.Ltd.
• Swiss Precision Diagnostics GmbH
• Artron Laboratories Inc.
• Wondfo Biotech Co.Ltd.
• AdvaCare Pharma
• Proov
• Shanghai Chemtron Biotech Co.Ltd.
• Apollo Pharmacy Pvt. Ltd.
• Ava Science Inc.
• Clinical Guard Ltd.
• Fairhaven Health LLC
• Femometer Ltd.
• iProven
• Megna Health Inc.
• Easy Healthcare Corporation (Premom)
• Biotrol Laboratories Private Limited
• Tulip Diagnostics Pvt. Ltd.
What Is The Most Dominant Region In The Ovulation Testing Kits Market?
North America was the largest region in the ovulation testing kits market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ovulation testing kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
